Purpose: To review a series of extramacular choroidal neovascular membranes (CNVMs) in the context of their choroidal features, as determined by optical coherence tomography (OCT). Methods: Patients with extramacular CNVMs were identified from a tertiary care center through a review of records. The charts and cases were reviewed using multimodal imaging including fundus photography, OCT, fluorescein angiography (FA), and indocyanine angio graphy (ICG). Results: Of six patients with extramacular CNVMs evaluated in this series, four patients (66.7%) exhibited pachychoroidopathy on OCT imaging under or adjacent to the extramacular CNVM. All four of these patients also exhibited pachychoroidopathy in the macular OCT distant from the CNVM. Conclusion: Pachychoroidopathy is implicated in some cases of extramacular CNVMs. This represents the first report, to our knowledge, of pachychoroidopathy in extramacular CNVM.
Introduction
"Pachychoroidopathy" is a recently coined term to describe the shared choroidal features of thickened choroid and dilated outer choroidal vessels that link a spectrum of retinal conditions including pigmentary change, central serous chorioretinopathy (CSCR), some cases of type 1 (subretinal pigment epithelium [RPE] ) choroidal neo vascularization (CNV), and polypoidal choroidal vasculopathy (PCV). [1] [2] [3] Although controversy remains regarding pachychoroidopathy, recent studies suggest that the genetics and pathogenesis of pachychoroidopathy, as well as response to therapies, may be distinct from that seen in related conditions such as agerelated macular degeneration (AMD). Previously, pachychoroidopathyrelated type 1 CNV, termed "pachychoroid neovasculopathy," has been described in patients with choroidal neo vascular membranes (CNVMs) localized to the central macula. To evaluate the role of pachychoroidopathy in extramacular CNVMs, also known as peripheral disciform lesions, we retrospectively reviewed a series of cases of extramacular CNVMs in the context of their associated choroidal findings.
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gupta et al lamp biomicroscopy, indirect ophthalmoscopy, color fun dus photography (Optos™ Panoramic 200A; Optos PLC, Dunfermline, UK), and enhanceddepth imaging optical coherence tomography (EDIOCT; Heidelberg Spectralis; Heidelberg Engineering, Inc, Vista, CA, USA). EDIOCT was performed through the macula in all cases, as well as through the CNVM lesion itself whenever possible. Fluorescein angiography (FA) and indocyanine green angio graphy (ICG) were also reviewed, when available. The study period was January 2015 to December 2015. This study was approved by the Institutional Review Board of Weill Cornell Medicine and was performed in a Health Care Portability and Accountability Act compliant manner. No informed consent was obtained as this was a retrospective case review study.
Results
The six cases reported had an average age of 74.8 years (range 56 to 87 years). Five were female and one was male. Average followup was 20 months (range 2 to 35 months). The clinical and choroidal features of the six cases are sum marized in Table 1 .
Of the six cases reviewed, four (66.7%; cases 1-4) exhibited pachychoroidopathy (Figures 1-4) . These patients were all females ranging in age from 56 to 84 years. Two of these patients presented with photopsia (cases 1 and 3). All four patients exhibited an extramacular CNVM, with macular EDIOCT revealing thick choroid with dilated outer choroidal vessels. EDIOCT obtained through the CNVM itself (cases 1-3) revealed Type 1 CNVM overlying thick choroid with dilated outer choroidal vessels which were inwardly displaced and abutting the RPE. EDIOCT was not possible through the large hemorrhagic pigment epithelial detachment (PED) in case 4, but OCT in the retina adjacent to this lesion similarly revealed thick choroid and dilated outer choroidal vessels. FA was performed in each case and revealed leakage consistent with CNVM in three patients (cases 1-3); case 4 exhibited blockage by the large subRPE hemorrhage. ICG was performed in only one case (case 2) and revealed polypoidal neovascular lesions in the area of extramacular CNVM, as well as a few small polypoid lesions in the fellow eye ( Figure 2C and D) . Two patients (cases 1 and 3) were treated with intravitreal antivascular endothelial growth factor (VEGF) injections due to increased exudation or symptomatic CNVM. Case 1 noted no significant response to antiVEGF therapy nor of her photopsia, while case 3 exhibited stable exudation but resolution of photopsia after therapy. All four cases main tained stable visual acuity at last followup. Figure 1A) . EDIOCT of the macula revealed thick choroid with subtle choroidal folds overlying dilated outer choroidal vessels OD ( Figure 1B) . EDIOCT through the superonasal exudative lesion OD revealed thick ened choroid and dilated outer choroidal vessels with overlying RPE disturbance and type 1 neovascularization ( Figure 1C) . The dilated choroidal vessels were inwardly displaced and abutted the RPE. Ultrawidefield FA revealed leakage from an occult choroidal neovascular membrane ( Figure 1D and E). An ICG was not performed. The lesion was observed, but increased exudation and symptoms were noted 11 months later, prompting treatment with intravitreal ranibizumab (Lucentis ® ; HoffmanLa Roche Ltd., Basel, Switzerland) 0.5 mg OD and subsequently, aflibercept 2 mg (EYLEA, Regeneron Pharma ceuticals, Inc., Tarrytown, NY, USA) twice, with no signifi cant improvement. At the most recent followup, 35 months after initial presentation, exudation was noted to have further increased ( Figure 1F ), though the macula remains spared and VA is 20/20. The patient declined further intervention such as antiVEGF therapy or photodynamic therapy.
Two of the six cases (cases 5-6) exhibited extramacular CNVM without pachychoroidopathy ( Figures 5 and 6 ). Both were male patients in their 80s who presented with macular drusen and RPE changes and incidentally noted extramacular CNVM with hemorrhage in the far temporal periphery. EDIOCT through the macula revealed RPE changes and markedly thinned choroid. The lesions were too peripheral to perform EDIOCT through the CNVM itself.
Discussion
Studies have recently described "pachychoroidopathy", as a spectrum of conditions (including pigmentary changes, CSCR, some cases of type 1 neovascularization, and poly poidal choroidal vasculopathy) that share common features of thickened choroid and dilated outer choroidal vessels. [1] [2] [3] On the milder side of this spectrum is pachychoroid pigment epitheliopathy (PPE), in which choroidal thickening and dilated outer choroidal vessels are associated with overly ing RPE disturbances. PPE may be a forme fruste of CSCR, sharing the underlying choroidal pathology but lacking the classic macular subretinal fluid or gravitational tracks [4] [5] [6] [7] and CSCR and PCV. [8] [9] [10] [11] [12] The newly conceived pachychoroidopathy suggests that a pathologic choroidal process characterized by dilated outer choroidal vessels and thick choroid is the underlying common denominator.
Thus far, pachychoroid neovasculopathy has been reported in patients with CNVMs in the central macula. 1, 3 There are no reports of pachychoroid neovasculopathy in cases with extramacular CNVMs. To evaluate whether pachychoroidopathy may be implicated in extramacular CNVMs, we retrospectively evaluated choroidal features in the central macula and, when possible, under the CNVMs, in a series of six extramacular CNVM cases evaluated at Weill Cornell Medical College. This series is the first, to our knowledge, to examine these peripheral CNVMs in the context of their choroidal findings.
In this small retrospective case series, four of six cases of extramacular CNVMs exhibited pachychoroidopa thy -ie, thickened choroids and dilated outer choroidal vessels under or adjacent to the CNVM. This represents the first report of pachychoroid neovasculopathy outside of the central macula. Another feature of pachychoroid neovasculopathy is inward displacement of the dilated outer choroidal vessels below the lesions, such that they are abutting the RPE. This was noted in all four cases. Two patients with pachychoroidopathy presented with symptoms of photopsia. Whether this symptomatology is related to the underlying condition is unclear. In all four cases demonstrating pachychoroidopathy under or adja cent to the extramacular CNVM, the macular OCT also revealed pachychoroidopathy. This suggests that even in cases where the extramacular CNVM itself is too peripheral for OCT imaging, choroidal features visible in the macula itself may support a diagnosis of pachychoroid neovas culopathy. This finding also begs the question of whether presence of such an extramacular CNVM in the setting of pachychoroidopathy in the macula as well suggests an underlying risk for future pigment epitheliopathy or CNVM risk in the macula itself. Further studies with more patients and more longterm followup are necessary.
Both cases of extramacular CNVMs without pachy choroid features also had agerelated macular degeneration, and their macular choroids exhibited marked thinning, as is common in agerelated macular degeneration. Interestingly, the extramacular CNVMs in both of these cases were also far more peripheral than those noted in the four cases with pachychoroidopathy.
Extramacular CNVMs (also known as peripheral disci form lesions, extramacular disciform, or peripheral exudative hemorrhagic chorioretinopathy) comprise a broad diagnostic category. It is now well known that many of these extra macular CNVMs are PCV lesions, 13 although large studies evaluating extramacular CNVMs have demonstrated both the absence and presence of PCVlike polyps. [13] [14] [15] Since PCV is implicated in some extramacular CNVMs and also falls within the pachychoroid spectrum, the pachychoroidopathy noted in cases 1-4 in this series may reflect the known rela tionship of PCV to extramacular CNVMs. Indeed, in the current study, only one patient received ICG angiography (case 2), and that patient exhibited polypoidal changes con sistent with PCV. ICG was not performed or was unable to be performed due to the far peripheral location of the CNVMs in the other cases. The lack of ICG for the other cases is a major limitation of this study, as it is therefore unclear whether there were any cases of extramacular pachychoroidopathy in the absence of PCV features. If pachychoroidopathy were demonstrated in the absence of polyps on ICG in these lesions, pachychoroidopathy may offer an etiology for lesions previously considered idiopathic due to absence of polyps. Prior reports have demonstrated macular pachychoroid neovasculopathy in the absence of PCV. 1, 3 Further studies of pachychoroid extramacular CNVMs with more extensive ICG evaluation are necessary.
In addition to providing a unifying theme for several related conditions, as well as potentially offering a diagnosis for lesions previously thought to be idiopathic, the conception of pachychoroidopathy may have diagnostic and therapeutic implications. A recent genetic study evaluating eleven AMD susceptibility genes, including complement factor H and ARMS2 rs10490924 found that patients with pachychoroid neovasculopathy exhibited markedly less susceptibility than those with AMD. 16 This suggests that a distinct pathogenesis may be implicated in these pachychoroiddriven diseases. Consistent with this finding, we noted that both cases of extramacular CNVM without pachychoroid features in the current study exhibited underlying AMD. Similarly, it is well known that several pachychoroid diseases, including chronic CSCR and PCV, may respond less to antiVEGF agents and better to photodynamic therapy, than AMD. Thus, the distinction between neovascularization related to or unrelated to pachychoroidopathy may have important implications for therapeutics. Consistent with this, one patient in this series (case 1) with pachychoroid neovasculopathy was treated with antiVEGF agents with no significant response in exam or symptoms; photodynamic therapy was offered, but the patient deferred. This study had several limitations. The number of reported cases is small. ICG was not performed or was unable to be performed (due to the far peripheral location of the lesions) in most of the cases evaluated; widefield FA was used instead. As discussed above, ICG imaging to confirm absence or presence of polypoidal lesions would be instructive. In its absence, it is not possible to determine whether the pachy choroidopathy noted in these extramacular CNVMs reflects the known relation of these lesions to PCV or if there exists cases of extramacular pachychoroid neovasculopathy in the absence of PCV. Finally, the far peripheral location of the extramacular CNVMs in two cases, both of which were felt not to exhibit pachychoroidopathy, prevented the abilitiy to perform OCT through the lesion itself. In both of these cases, choroidal features in the macula were used as a surrogate and revealed thin choroid not consistent with pachychoroidopathy. If the pathology in these extramacular CNVMs is a focal choroidopathy localized to the region of the CNVM itself, using macular choroidal findings to inform the diagnosis of peripheral CNVMs may not be appropriate. However, we noted in this series that in all four cases where subCNVM OCTs were able to be performed (cases 1-4), the choroidal findings in the macula mirrored those in near the lesion itself.
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